Petros Gatsios/LinkedIn
Nov 5, 2025, 06:51
Petros Gatsios Explains Why Europe Must Become Self-Sufficient in Maintaining Its Plasma Supply
PPTA Europe shared on LinkedIn:
”Plasma-derived medicinal products (PDMPs) are vital for patients with rare and serious conditions and can’t be made in a lab.
Yet the supply of these medicines is more important than ever.
In a guest article published in Tagesspiegel Background Gesundheit and E-Health, Petros Gatsios, Chairman of the Plasma Protein Therapeutics Association Germany, explains why Europe must become self-sufficient in maintaining its plasma supply and suggests patient-centric policies to better secure future supplies.
Read more about how Germany can lead the way toward a resilient, self-sufficient model in Europe.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 04:02William Wallace: Does Fish Oil Increase Atrial Fibrillation Risk?
-
Aug 24, 2026, 02:48Alexandru Stieber: Large-Vessel Vasculitis – Clinical Patterns and Treatment
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful